Factors Associated with Breakthrough Fungemia Caused by <i>Candida</i> , <i>Trichosporon</i> , or Fusarium Species in Patients with Hematological Disorders-Reference-Cited by-同舟云学术

Factors Associated with Breakthrough Fungemia Caused by Candida , Trichosporon , or Fusarium Species in Patients with Hematological Disorders

Published:2022-03-15 Issue:3 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Kimura Muneyoshi¹^ORCID,Asano-Mori Yuki²,Sakoh Takashi¹,Abe Masahiro³,Ueno Keigo³,Hoshino Yasutaka³,Nakamura Shigeki³⁴,Umeyama Takashi³,Yamagoe Satoshi³,Miyazaki Yoshitsugu³^ORCID,Baba Masaru¹,Okada Chikako¹,Ogura Sho¹,Mitsuki Takashi⁵,Yamaguchi Kyosuke²,Yuasa Mitsuhiro²,Kaji Daisuke²,Kageyama Kosei²,Nishida Aya⁵,Taya Yuki²,Ishiwata Kazuya⁵,Takagi Shinsuke²,Yamamoto Hisashi²,Yamamoto Go²,Uchida Naoyuki²⁶,Wake Atsushi⁵⁶,Taniguchi Shuichi²⁶,Araoka Hideki¹⁶^ORCID

Affiliation:

1. Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan

2. Department of Hematology, Toranomon Hospital, Tokyo, Japan

3. Department of Fungal Infection, National Institute of Infectious Diseases, Tokyo, Japan

4. Department of Microbiology, Tokyo Medical University, Tokyo, Japan

5. Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan

6. Okinaka Memorial Institute for Medical Research, Tokyo, Japan

Abstract

Limited data are available on breakthrough fungemia, defined as fungemia that develops on administration of antifungal agents, in patients with hematological disorders. We reviewed the medical and microbiological records of adult patients with hematological diseases who had breakthrough fungemia between January 2008 and July 2019 at Toranomon Hospital and Toranomon Hospital Kajigaya in Japan.

Funder

Japan Agency for Medical Research and Development

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.02081-21

Reference30 articles.

1. Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

2. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer

3. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders